IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — FLNT

Balance Sheet

(in millions USD)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents10.309.254.934.836.594.9711.6620.5120.9826.5733.1126.4028.9415.6225.1432.66
Accounts Receivable20.0432.1331.2337.0252.6455.0653.4248.5258.1256.7667.5577.9965.0276.5765.9158.00
Total Current Assets49.4349.5546.9551.2366.2867.1571.4277.1089.0488.91102.97106.4896.1194.3992.7293.97
Property, Plant & Equipment0.130.140.190.230.360.430.500.690.780.861.061.161.301.641.832.03
Goodwill0.000.000.000.000.000.001.261.2630.9733.35110.78110.78166.18165.09165.09165.09
Intangible Assets16.7018.8619.6220.9922.6723.7726.1427.7128.5327.6530.7132.8734.9438.0540.4843.10
Total Non-current Assets*22.8426.5127.5226.2729.6631.3532.1634.9966.0468.26150.05152.66210.69215.15218.15221.32
Total Assets72.2776.0674.4777.4995.9598.50103.58112.09155.08157.17253.02259.14306.80309.54310.87315.29
Accounts Payable7.489.388.728.517.907.818.8311.8413.3012.9314.9217.0412.7816.1816.3613.48
Total Current Liabilities52.2148.4249.6551.6670.4169.5473.5372.1753.9854.4751.2359.5949.5352.9948.3248.12
Long-term Debt28.0326.0423.1825.6037.9433.2930.9831.8037.9939.4036.7837.9639.1546.5148.9350.10
Total Non-current Liabilities*6.786.065.703.805.561.501.304.4332.9739.7741.7443.4345.0948.1754.2054.96
Total Liabilities58.9954.4755.3555.4675.9771.0474.8376.6086.9594.2592.97103.0294.62101.17102.52103.08
Retained Earnings(443.32)(433.84)(426.29)(419.06)(407.36)(399.42)(387.79)(379.62)(345.99)(350.24)(250.81)(253.92)(196.98)(198.80)(196.35)(191.17)
Total Stockholder Equity13.2921.5919.1222.0419.9827.4528.7535.4968.1462.92160.05156.12212.18208.38208.35212.21

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Total Revenue44.8561.8247.0344.7155.2165.4164.5258.7265.9872.7666.2482.1577.2584.6689.0598.3689.0699.8485.8673.38
Research & Development2.822.882.622.943.403.604.124.724.844.394.514.624.944.184.624.804.564.464.463.43
Selling, General & Admin5.718.818.568.758.589.419.078.8610.3710.348.733.9412.3319.6210.8811.6911.2911.7013.2811.53
Operating Income(3.91)0.16(6.30)(7.11)(7.08)(5.44)(3.89)(10.38)(3.95)(1.78)(33.93)6.74(31.15)(67.20)0.63(51.39)(1.63)4.42(2.05)(4.75)
Interest Expense0.610.780.710.700.88--1.281.011.420.780.940.800.690.630.520.430.380.340.410.43
Pretax Income(5.35)(4.24)(7.57)(7.33)(8.04)(5.34)(7.98)(12.40)(5.37)(2.57)(34.87)5.94(31.84)(67.83)0.11(51.82)(2.01)4.08(2.45)(5.18)
Tax Provision0.00(0.12)(0.01)(0.11)0.23(1.91)(0.04)(0.77)0.91(0.67)(1.24)1.690.10(0.34)(3.00)5.120.000.250.000.00
Net Income(5.35)(4.12)(7.56)(7.22)(8.27)(3.43)(7.94)(11.63)(6.28)(1.90)(33.63)4.25(31.94)(67.49)3.11(56.94)(2.01)3.83(2.45)(5.18)
Basic EPS(0.17)(0.09)(0.27)(0.30)(0.39)(0.12)(0.48)(0.75)(0.45)(0.02)(0.41)0.05(0.39)(0.83)0.04(0.70)(0.02)0.04(0.03)(0.06)
Diluted EPS(0.17)(0.09)(0.27)(0.30)(0.39)(0.12)(0.48)(0.75)(0.45)(0.02)(0.41)0.05(0.39)(0.83)0.04(0.70)(0.02)0.04(0.03)(0.06)

Cash Flow Statement

(in millions USD)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow5.112.79(7.30)0.942.11(2.14)1.24(13.07)(0.13)(1.56)7.64(2.84)4.89(5.17)9.08(0.17)(1.78)19.36(6.27)(5.64)
Capital Expenditures0.060.020.020.03--0.010.000.00--0.000.000.02--0.010.00-0.000.010.010.000.00
Free Cash Flow*5.062.77(7.32)0.90--(2.15)1.24(13.07)--(1.56)7.64(2.86)--(5.18)9.08(0.17)(1.78)19.35(6.27)(5.64)
Investing Cash Flow(1.48)(1.47)(1.66)(1.66)(1.57)(1.48)(1.19)(1.75)(1.80)(1.74)(1.73)(1.26)(2.38)(1.14)(1.12)(1.13)(2.05)(0.73)(0.70)(0.72)
Financing Cash Flow(6.27)2.3711.611.96(5.15)6.481.369.59(2.22)(1.41)(6.39)(1.49)(1.49)(1.25)(1.25)(1.25)(1.70)(1.25)(2.55)(1.16)

* Derived from reported values